Finals results of the “Initiation of Anticoagulation in Cardioembolic stroke (IAC)” study: anticoagulation timing was not associated with early recurrence. Tushar Trivedi Daniyal Asad Amre Nouh Mithilesh Siddu Brian Mac Grory Aidan Azher Mani Veerasamy MD onlinelibrary.wiley.com/doi/abs/10.100…

Findings from the IAC multicenter retrospective registry of patients with acute cardioembolic stroke: treatment with heparin/LMWH increased risk of sICH and DOAC treatment (vs warfarin) was associated with reduced ischemic event risk. Stroke AHA/ASA doi.org/10.1161/STROKE…

Endothelial exocytosis may explain some of the multifocal small vessel strokes seen in COVID. May also account for why those with preexisting vascular disease do worse since this could exacerbate feedback loop. Severe COVID-19 is a Microvascular Disease ahajournals.org/doi/10.1161/CI…

Great work! Congratulations Shadi Yaghi and team. Real word data from ACTION-CVT supports the use of DOACs for CVT. This would certainly encourage practice change ahajournals.org/doi/10.1161/ST…